DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

Phase 2

Completed

Conditions: Malignant Mesothelioma

Interventions: Other: clinical observation
Drug: pemetrexed disodium

First Posted Date: 2010-03-12

Last Posted Date: 2021-08-18

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 72

Registration Number: NCT01085630

Locations: 🇺🇸
Essentia Health - Duluth Clinic, Duluth, Minnesota, United States
🇺🇸
Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States
🇺🇸
CCOP - Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States

and more 142 locations

DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701

Completed

Conditions: Lymphoma

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2010-01-27

Last Posted Date: 2017-06-27

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 78

Registration Number: NCT01057459

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 3

Terminated

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: celecoxib
Drug: gemcitabine hydrochloride
Other: placebo
Drug: pemetrexed disodium

First Posted Date: 2010-01-01

Last Posted Date: 2018-07-23

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 313

Registration Number: NCT01041781

Locations: 🇺🇸
Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States
🇺🇸
Toledo Clinic Cancers Centers - Maumee, Maumee, Ohio, United States
🇺🇸
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States

and more 395 locations

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2

Completed

Conditions: Leukemia
Lymphoma

Interventions: Biological: rituximab
Drug: busulfan
Drug: cyclophosphamide
Drug: fludarabine phosphate
Drug: methotrexate
Drug: sirolimus
Drug: tacrolimus
Procedure: allogeneic stem cell transplant

First Posted Date: 2009-12-07

Last Posted Date: 2023-05-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 68

Registration Number: NCT01027000

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, United States

and more 22 locations

Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Lung Cancer

Interventions: Other: placebo
Biological: Seneca Valley virus-001

First Posted Date: 2009-11-20

Last Posted Date: 2017-05-08

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 59

Registration Number: NCT01017601

Locations: 🇺🇸
El Camino Hospital Cancer Center, Mountain View, California, United States
🇺🇸
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain, Connecticut, United States
🇺🇸
Kalispell Medical Oncology at KRMC, Kalispell, Montana, United States

and more 193 locations

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Completed

Conditions: Bladder Cancer
Breast Cancer
Head and Neck Cancer
Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2009-11-18

Last Posted Date: 2017-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 69

Registration Number: NCT01015963

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Genetic: fluorescence in situ hybridization
Genetic: loss of heterozygosity analysis
Genetic: polymerase chain reaction
Other: flow cytometry
Other: immunohistochemistry staining method

First Posted Date: 2009-10-30

Last Posted Date: 2016-07-18

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 135

Registration Number: NCT01004523

Locations: 🇺🇸
Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States
🇺🇸
St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States
🇺🇸
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 35 locations

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Completed

Conditions: Leukemia

Interventions: Genetic: fluorescence in situ hybridization
Genetic: mutation analysis
Genetic: nucleic acid sequencing
Genetic: polymerase chain reaction
Genetic: western blotting
Other: flow cytometry
Other: laboratory biomarker analysis

First Posted Date: 2009-10-30

Last Posted Date: 2022-08-03

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 600

Registration Number: NCT01005368

Locations: 🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
🇺🇸
SUNY Upstate Medical University Hospital, Syracuse, New York, United States
🇺🇸
Kinston Medical Specialists, Kinston, North Carolina, United States

and more 32 locations

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Other: diagnostic laboratory biomarker analysis

First Posted Date: 2009-10-30

Last Posted Date: 2019-01-17

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 631

Registration Number: NCT01004887

Locations: 🇺🇸
Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States
🇺🇸
Grant Medical Center Cancer Care, Columbus, Ohio, United States
🇺🇸
Mount Carmel Health - West Hospital, Columbus, Ohio, United States

and more 104 locations

Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

Completed

Conditions: Leukemia

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2009-10-30

Last Posted Date: 2022-08-03

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 2034

Registration Number: NCT01004965

Locations: 🇺🇸
CancerCare of Maine at Eastern Maine Medical Center, Bangor, Maine, United States
🇺🇸
CCOP - North Shore University Hospital, Manhasset, New York, United States
🇺🇸
SUNY Upstate Medical University Hospital, Syracuse, New York, United States

and more 43 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy